| Name | Title | Contact Details |
|---|---|---|
Dean Watson |
Chief Technology Officer | Profile |
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.
Cyberonics, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
SouthwestMedical.com is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
SHL MEDICAL, USA is a Florham Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ziehm Medical is a Reno, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.